Correspondence on "Differences in First-Line Chemosensitivity Assessed by KELIM in Advanced Serous Ovarian Cancer: Evidence From Western and Japanese Trials in a Gynecologic Cancer InterGroup (GCIG) Meta-Analysis" by Pauline Corbaux to the Editor of the International Journal of Gynecological Cancer.